| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Organ Prolapse | 25 | 2020 | 47 | 6.550 |
Why?
|
| Robotics | 19 | 2017 | 127 | 5.970 |
Why?
|
| Gynecologic Surgical Procedures | 17 | 2020 | 48 | 5.050 |
Why?
|
| Hysterectomy | 12 | 2020 | 49 | 4.210 |
Why?
|
| Vagina | 17 | 2020 | 59 | 3.420 |
Why?
|
| Fecal Incontinence | 14 | 2018 | 23 | 2.910 |
Why?
|
| Surgical Mesh | 12 | 2020 | 49 | 2.590 |
Why?
|
| Uterine Prolapse | 8 | 2017 | 21 | 2.560 |
Why?
|
| Laparoscopy | 10 | 2020 | 184 | 1.920 |
Why?
|
| Female | 73 | 2020 | 20375 | 1.530 |
Why?
|
| Postoperative Complications | 8 | 2020 | 828 | 1.430 |
Why?
|
| Humans | 76 | 2020 | 32969 | 1.250 |
Why?
|
| Urinary Incontinence | 5 | 2018 | 48 | 1.180 |
Why?
|
| Reconstructive Surgical Procedures | 3 | 2020 | 198 | 1.170 |
Why?
|
| Surgical Procedures, Operative | 3 | 2014 | 78 | 1.140 |
Why?
|
| Urinary Bladder | 6 | 2019 | 183 | 1.120 |
Why?
|
| Anal Canal | 5 | 2014 | 20 | 1.090 |
Why?
|
| Pelvic Floor | 6 | 2017 | 20 | 1.000 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2019 | 12 | 0.980 |
Why?
|
| Middle Aged | 42 | 2020 | 12203 | 0.970 |
Why?
|
| Cystitis, Interstitial | 4 | 2020 | 53 | 0.970 |
Why?
|
| Hospitals, University | 3 | 2014 | 31 | 0.900 |
Why?
|
| Adnexal Diseases | 2 | 2016 | 6 | 0.900 |
Why?
|
| Hysteroscopy | 2 | 2015 | 4 | 0.880 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2015 | 13 | 0.880 |
Why?
|
| Aged | 35 | 2020 | 10637 | 0.860 |
Why?
|
| Ovariectomy | 2 | 2016 | 162 | 0.860 |
Why?
|
| Urinary Incontinence, Stress | 6 | 2018 | 66 | 0.840 |
Why?
|
| Urogenital Surgical Procedures | 2 | 2014 | 7 | 0.830 |
Why?
|
| Surgery Department, Hospital | 2 | 2014 | 7 | 0.830 |
Why?
|
| Urologic Surgical Procedures | 4 | 2014 | 64 | 0.790 |
Why?
|
| Urinary Catheterization | 2 | 2020 | 16 | 0.770 |
Why?
|
| Suture Techniques | 3 | 2020 | 61 | 0.770 |
Why?
|
| Sexually Transmitted Diseases | 4 | 2010 | 47 | 0.740 |
Why?
|
| Abdominal Wall | 2 | 2013 | 22 | 0.720 |
Why?
|
| Risk Factors | 17 | 2020 | 4001 | 0.670 |
Why?
|
| Sacrum | 4 | 2016 | 21 | 0.670 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2011 | 57 | 0.660 |
Why?
|
| Treatment Outcome | 14 | 2020 | 3460 | 0.660 |
Why?
|
| Urinary Retention | 1 | 2020 | 7 | 0.650 |
Why?
|
| Adult | 26 | 2020 | 9586 | 0.650 |
Why?
|
| Remote Consultation | 1 | 2020 | 13 | 0.640 |
Why?
|
| Contraception Behavior | 2 | 2010 | 3 | 0.640 |
Why?
|
| Obstetric Labor Complications | 3 | 2014 | 17 | 0.640 |
Why?
|
| Contraception | 2 | 2010 | 11 | 0.640 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 17 | 0.630 |
Why?
|
| Outpatients | 1 | 2020 | 57 | 0.630 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 49 | 0.630 |
Why?
|
| Prisoners | 2 | 2010 | 12 | 0.630 |
Why?
|
| Polyneuropathies | 1 | 2019 | 11 | 0.600 |
Why?
|
| Sexuality | 1 | 2019 | 12 | 0.590 |
Why?
|
| Recovery of Function | 1 | 2020 | 205 | 0.590 |
Why?
|
| Urinary Diversion | 1 | 2019 | 27 | 0.590 |
Why?
|
| Fibromyalgia | 1 | 2019 | 26 | 0.590 |
Why?
|
| Retrospective Studies | 15 | 2020 | 3708 | 0.580 |
Why?
|
| Hernia, Inguinal | 1 | 2018 | 4 | 0.580 |
Why?
|
| Pubic Symphysis Diastasis | 1 | 2018 | 3 | 0.580 |
Why?
|
| Perineum | 2 | 2018 | 18 | 0.570 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 98 | 0.570 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 102 | 0.570 |
Why?
|
| Telemedicine | 1 | 2020 | 118 | 0.570 |
Why?
|
| Cystectomy | 1 | 2019 | 106 | 0.560 |
Why?
|
| Ovarian Neoplasms | 2 | 2016 | 103 | 0.550 |
Why?
|
| Clinical Competence | 4 | 2020 | 338 | 0.530 |
Why?
|
| Urinary Bladder, Overactive | 2 | 2014 | 16 | 0.530 |
Why?
|
| Control Groups | 1 | 2016 | 5 | 0.500 |
Why?
|
| Diabetes Complications | 2 | 2015 | 183 | 0.500 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2019 | 192 | 0.500 |
Why?
|
| European Continental Ancestry Group | 5 | 2013 | 1163 | 0.480 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 47 | 0.480 |
Why?
|
| Endometrial Neoplasms | 2 | 2014 | 48 | 0.480 |
Why?
|
| Delivery, Obstetric | 2 | 2014 | 58 | 0.480 |
Why?
|
| Time Factors | 8 | 2020 | 2195 | 0.470 |
Why?
|
| Urethra | 2 | 2018 | 100 | 0.470 |
Why?
|
| Quality of Life | 4 | 2020 | 976 | 0.460 |
Why?
|
| Prospective Studies | 13 | 2020 | 2338 | 0.460 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2010 | 1068 | 0.460 |
Why?
|
| Gene Expression | 1 | 2016 | 336 | 0.450 |
Why?
|
| Foreign-Body Migration | 1 | 2014 | 10 | 0.440 |
Why?
|
| Rectocele | 1 | 2014 | 2 | 0.430 |
Why?
|
| Follow-Up Studies | 8 | 2018 | 2287 | 0.430 |
Why?
|
| Digital Rectal Examination | 1 | 2014 | 10 | 0.430 |
Why?
|
| Rectum | 1 | 2014 | 17 | 0.430 |
Why?
|
| Hysterectomy, Vaginal | 3 | 2020 | 7 | 0.420 |
Why?
|
| Incidental Findings | 1 | 2014 | 26 | 0.410 |
Why?
|
| United States Food and Drug Administration | 1 | 2013 | 52 | 0.400 |
Why?
|
| African Americans | 5 | 2013 | 1425 | 0.400 |
Why?
|
| Equipment and Supplies | 2 | 2015 | 16 | 0.400 |
Why?
|
| Gynecology | 4 | 2020 | 20 | 0.400 |
Why?
|
| Constipation | 1 | 2013 | 11 | 0.400 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2014 | 360 | 0.400 |
Why?
|
| Parity | 1 | 2013 | 19 | 0.390 |
Why?
|
| Task Performance and Analysis | 1 | 2012 | 54 | 0.380 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 2012 | 4 | 0.370 |
Why?
|
| Cross-Sectional Studies | 7 | 2015 | 1582 | 0.370 |
Why?
|
| Pelvis | 1 | 2012 | 64 | 0.360 |
Why?
|
| Cesarean Section | 1 | 2013 | 113 | 0.350 |
Why?
|
| Sexual Behavior | 2 | 2010 | 125 | 0.350 |
Why?
|
| Intrauterine Devices | 2 | 2010 | 3 | 0.350 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 1152 | 0.340 |
Why?
|
| Depression | 1 | 2014 | 448 | 0.340 |
Why?
|
| Colposcopes | 1 | 2010 | 1 | 0.330 |
Why?
|
| Laparoscopes | 1 | 2010 | 3 | 0.330 |
Why?
|
| Suburethral Slings | 3 | 2020 | 14 | 0.330 |
Why?
|
| Umbilicus | 1 | 2010 | 2 | 0.330 |
Why?
|
| Pregnancy | 5 | 2014 | 981 | 0.330 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 754 | 0.320 |
Why?
|
| Laminin | 1 | 2010 | 13 | 0.320 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 148 | 0.310 |
Why?
|
| Ovulation | 1 | 2009 | 7 | 0.300 |
Why?
|
| Age Factors | 5 | 2017 | 1202 | 0.300 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2009 | 4 | 0.300 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2009 | 13 | 0.290 |
Why?
|
| Ovary | 1 | 2009 | 59 | 0.290 |
Why?
|
| Health Services Needs and Demand | 1 | 2009 | 80 | 0.290 |
Why?
|
| Body Mass Index | 4 | 2018 | 909 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 209 | 0.280 |
Why?
|
| Premature Birth | 1 | 2009 | 72 | 0.270 |
Why?
|
| Commerce | 1 | 2008 | 69 | 0.270 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 4065 | 0.270 |
Why?
|
| United States | 9 | 2018 | 4133 | 0.270 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2020 | 195 | 0.260 |
Why?
|
| Obesity | 1 | 2014 | 1179 | 0.260 |
Why?
|
| Defecation | 2 | 2017 | 6 | 0.250 |
Why?
|
| Recurrence | 3 | 2016 | 282 | 0.250 |
Why?
|
| Vacuum Extraction, Obstetrical | 2 | 2018 | 4 | 0.240 |
Why?
|
| Pilot Projects | 3 | 2018 | 566 | 0.220 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 599 | 0.210 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 883 | 0.200 |
Why?
|
| Sutures | 2 | 2020 | 20 | 0.190 |
Why?
|
| Postmenopause | 2 | 2017 | 427 | 0.190 |
Why?
|
| Urinary Tract Infections | 2 | 2020 | 46 | 0.190 |
Why?
|
| Comorbidity | 2 | 2014 | 573 | 0.180 |
Why?
|
| Obstetrics | 2 | 2020 | 28 | 0.180 |
Why?
|
| Nurses | 2 | 2018 | 15 | 0.180 |
Why?
|
| Analysis of Variance | 2 | 2013 | 460 | 0.180 |
Why?
|
| Polydioxanone | 1 | 2020 | 1 | 0.170 |
Why?
|
| Polytetrafluoroethylene | 1 | 2020 | 15 | 0.160 |
Why?
|
| Infection Control | 1 | 2020 | 29 | 0.160 |
Why?
|
| Vulva | 1 | 2020 | 1 | 0.160 |
Why?
|
| Vaginal Diseases | 1 | 2020 | 7 | 0.160 |
Why?
|
| Vulvar Diseases | 1 | 2020 | 4 | 0.160 |
Why?
|
| Endometriosis | 1 | 2020 | 25 | 0.160 |
Why?
|
| Preoperative Period | 2 | 2018 | 34 | 0.160 |
Why?
|
| Educational Measurement | 1 | 2020 | 119 | 0.160 |
Why?
|
| Southeastern United States | 2 | 2010 | 80 | 0.160 |
Why?
|
| Laser Therapy | 1 | 2020 | 56 | 0.150 |
Why?
|
| Risk Assessment | 3 | 2017 | 1469 | 0.150 |
Why?
|
| Menopause | 1 | 2020 | 97 | 0.150 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 67 | 0.150 |
Why?
|
| Anesthesia | 1 | 2019 | 64 | 0.150 |
Why?
|
| Estrogens | 1 | 2020 | 169 | 0.140 |
Why?
|
| Models, Educational | 1 | 2018 | 18 | 0.140 |
Why?
|
| Dietary Fiber | 1 | 2018 | 20 | 0.140 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 188 | 0.130 |
Why?
|
| Recovery Room | 1 | 2017 | 1 | 0.130 |
Why?
|
| Urination | 1 | 2017 | 16 | 0.130 |
Why?
|
| Reoperation | 2 | 2017 | 260 | 0.130 |
Why?
|
| Pelvic Pain | 1 | 2017 | 17 | 0.130 |
Why?
|
| Postoperative Hemorrhage | 1 | 2017 | 42 | 0.130 |
Why?
|
| Patient Satisfaction | 2 | 2020 | 240 | 0.130 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 98 | 0.120 |
Why?
|
| Cadaver | 1 | 2016 | 165 | 0.120 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 39 | 0.120 |
Why?
|
| RNA | 1 | 2016 | 87 | 0.120 |
Why?
|
| Diet | 1 | 2018 | 393 | 0.120 |
Why?
|
| Intestines | 1 | 2016 | 60 | 0.120 |
Why?
|
| Prosthesis Design | 1 | 2016 | 102 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2016 | 308 | 0.110 |
Why?
|
| Urology | 1 | 2015 | 31 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2016 | 1852 | 0.110 |
Why?
|
| Abdomen | 2 | 2012 | 46 | 0.110 |
Why?
|
| Hymen | 1 | 2014 | 1 | 0.110 |
Why?
|
| Observer Variation | 1 | 2014 | 96 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2017 | 325 | 0.100 |
Why?
|
| Incidence | 4 | 2018 | 1246 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 412 | 0.100 |
Why?
|
| Health Surveys | 2 | 2012 | 200 | 0.100 |
Why?
|
| Hip Fractures | 1 | 2013 | 30 | 0.100 |
Why?
|
| Retroperitoneal Space | 1 | 2013 | 20 | 0.100 |
Why?
|
| Exercise | 1 | 2018 | 688 | 0.100 |
Why?
|
| Young Adult | 4 | 2019 | 2738 | 0.100 |
Why?
|
| Benchmarking | 1 | 2013 | 25 | 0.100 |
Why?
|
| Obstetrical Forceps | 1 | 2013 | 3 | 0.100 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2013 | 2 | 0.100 |
Why?
|
| Labor Stage, Second | 1 | 2013 | 2 | 0.100 |
Why?
|
| Nortropanes | 1 | 2012 | 2 | 0.100 |
Why?
|
| Cholinergic Antagonists | 1 | 2012 | 10 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2016 | 370 | 0.100 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 102 | 0.100 |
Why?
|
| Efficiency | 1 | 2012 | 18 | 0.100 |
Why?
|
| Canada | 1 | 2012 | 64 | 0.090 |
Why?
|
| Diarrhea | 1 | 2013 | 58 | 0.090 |
Why?
|
| Prevalence | 4 | 2018 | 1002 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 1310 | 0.090 |
Why?
|
| Adnexa Uteri | 1 | 2012 | 1 | 0.090 |
Why?
|
| Ligaments | 1 | 2012 | 14 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2017 | 880 | 0.090 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 265 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 98 | 0.090 |
Why?
|
| Patient Preference | 1 | 2012 | 47 | 0.090 |
Why?
|
| Proportional Hazards Models | 3 | 2018 | 765 | 0.090 |
Why?
|
| Patient Selection | 1 | 2013 | 281 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 292 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 194 | 0.090 |
Why?
|
| Health Status | 1 | 2013 | 403 | 0.080 |
Why?
|
| Infertility, Female | 1 | 2010 | 6 | 0.080 |
Why?
|
| Body Weights and Measures | 1 | 2010 | 23 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2012 | 356 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 576 | 0.080 |
Why?
|
| Medically Underserved Area | 1 | 2010 | 23 | 0.080 |
Why?
|
| Colposcopy | 1 | 2010 | 4 | 0.080 |
Why?
|
| Intention | 1 | 2010 | 32 | 0.080 |
Why?
|
| Leiomyoma | 1 | 2010 | 15 | 0.080 |
Why?
|
| Equipment Design | 1 | 2010 | 179 | 0.080 |
Why?
|
| Contraceptive Agents, Female | 1 | 2010 | 15 | 0.080 |
Why?
|
| Uterine Neoplasms | 1 | 2010 | 29 | 0.080 |
Why?
|
| Needs Assessment | 1 | 2010 | 75 | 0.080 |
Why?
|
| Linkage Disequilibrium | 1 | 2010 | 185 | 0.080 |
Why?
|
| Haplotypes | 1 | 2010 | 220 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 199 | 0.080 |
Why?
|
| Poverty | 1 | 2010 | 116 | 0.080 |
Why?
|
| Prisons | 1 | 2009 | 5 | 0.080 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2010 | 100 | 0.080 |
Why?
|
| Choice Behavior | 1 | 2010 | 86 | 0.080 |
Why?
|
| Urodynamics | 1 | 2009 | 36 | 0.080 |
Why?
|
| Menarche | 1 | 2009 | 4 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 894 | 0.080 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2009 | 28 | 0.070 |
Why?
|
| Consent Forms | 1 | 2008 | 3 | 0.070 |
Why?
|
| Patient Rights | 1 | 2008 | 12 | 0.070 |
Why?
|
| Reference Values | 1 | 2009 | 238 | 0.070 |
Why?
|
| North Carolina | 1 | 2013 | 1550 | 0.070 |
Why?
|
| Cognition | 1 | 2012 | 553 | 0.070 |
Why?
|
| Estradiol | 1 | 2009 | 121 | 0.070 |
Why?
|
| Attitude to Health | 1 | 2009 | 163 | 0.070 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2007 | 1 | 0.070 |
Why?
|
| Women's Health | 1 | 2009 | 235 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 770 | 0.070 |
Why?
|
| Postoperative Period | 2 | 2018 | 99 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2009 | 203 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2009 | 821 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2009 | 694 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 682 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2017 | 369 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2016 | 467 | 0.050 |
Why?
|
| Urinary Bladder Diseases | 1 | 2020 | 20 | 0.040 |
Why?
|
| Male | 4 | 2020 | 19754 | 0.040 |
Why?
|
| Lasers, Gas | 1 | 2020 | 3 | 0.040 |
Why?
|
| Administration, Intravaginal | 1 | 2020 | 9 | 0.040 |
Why?
|
| Atrophy | 1 | 2020 | 46 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 196 | 0.040 |
Why?
|
| Water | 1 | 2019 | 61 | 0.040 |
Why?
|
| Adolescent | 2 | 2019 | 3643 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2019 | 59 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 644 | 0.040 |
Why?
|
| Patient Positioning | 1 | 2018 | 22 | 0.030 |
Why?
|
| Urethral Diseases | 1 | 2018 | 17 | 0.030 |
Why?
|
| Eating | 1 | 2018 | 74 | 0.030 |
Why?
|
| Cystocele | 1 | 2017 | 4 | 0.030 |
Why?
|
| Hernia | 1 | 2017 | 11 | 0.030 |
Why?
|
| Compliance | 1 | 2017 | 13 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 215 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2017 | 135 | 0.030 |
Why?
|
| Urine | 1 | 2017 | 65 | 0.030 |
Why?
|
| Organ Size | 1 | 2017 | 220 | 0.030 |
Why?
|
| Feces | 1 | 2016 | 43 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 156 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 95 | 0.030 |
Why?
|
| Hand Strength | 1 | 2016 | 102 | 0.030 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2014 | 4 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 684 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 517 | 0.030 |
Why?
|
| Education | 1 | 2014 | 37 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 185 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2016 | 238 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 258 | 0.030 |
Why?
|
| Directive Counseling | 1 | 2014 | 17 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2015 | 151 | 0.030 |
Why?
|
| Episiotomy | 1 | 2013 | 2 | 0.020 |
Why?
|
| Urinary Incontinence, Urge | 1 | 2012 | 2 | 0.020 |
Why?
|
| Benzilates | 1 | 2012 | 2 | 0.020 |
Why?
|
| Verbal Learning | 1 | 2012 | 8 | 0.020 |
Why?
|
| Communication | 1 | 2014 | 141 | 0.020 |
Why?
|
| Internet | 1 | 2014 | 201 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 187 | 0.020 |
Why?
|
| Attention | 1 | 2012 | 82 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 363 | 0.020 |
Why?
|
| Memory | 1 | 2012 | 191 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2012 | 160 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 783 | 0.020 |
Why?
|
| Sacrococcygeal Region | 1 | 2009 | 6 | 0.020 |
Why?
|